Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients

Yu Lin, Yi Hsin Liang, Jia Huei Tsai, Jau Yu Liau, Jin Tung Liang, Been Ren Lin, Ji Shiang Hung, Liang In Lin, Li Hui Tseng, Yih Leong Chang, Kun Huei Yeh, Ann Lii Cheng

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology